MMP9 and chronic obstructive pulmonary disease: Moreover, MMP9 expression and activity were significantly upregulated in the alveolar macrophages of patients with COPD, while they were decreased in response to metallopeptidase inhibitor 1 (TIMP1), supporting the proteolytic destruction of the lung parenchyma by proteolytic enzymes [72].